- Previous
- Next
26 December 2024
Inspiring Cancer Therapy
Immune checkpoint inhibitors, therapies which prevent cancers circumventing attack from the immune system, often fail because they don't activate the patient's immune system sufficiently. This study finds that mice with lung cancer muster an enduring immune response when such therapy is delivered as a nanoemulsion by nebuliser
Read the published research article here
Written by
- Image from work by Rong A, Zhaoguo Han, Meifang Zhou and Chaoqun Nie and colleagues
- Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin, China
- Image originally published with a Creative Commons Attribution 4.0 International (CC BY-NC 4.0)
- Published in Science Advances, November 2024
Search The Archive
Submit An Image
Like us on Facebook
Follow on Twitter
Follow on Tumblr
Follow on Instagram
What is BPoD?
BPoD stands for Biomedical Picture of the Day. Managed by the MRC Laboratory of Medical Sciences until Jul 2023, it is now run independently by a dedicated team of scientists and writers. The website aims to engage everyone, young and old, in the wonders of biology, and its influence on medicine. The ever-growing archive of more than 4000 research images documents over a decade of progress. Explore the collection and see what you discover. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.